Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle

Trial Profile

Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Oct 2018

At a glance

  • Drugs Rexlemestrocel-L (Primary)
  • Indications Heart failure
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Oct 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top